ICICI Securities Ltd | Retail Equity Research Revenues grew 20% YoY to | 1124 crore (I-direct estimate: | 1214 crore) mainly due to 35.5% YoY growth in Biologics to | 250 crore (Idirect estimate: | 239 crore) and 39.5% YoY growth in contract research to | 406 crore (I-direct estimate: | 425 crore) EBITDA margins increased 60 bps YoY to 21.2% (I-direct estimate: 20.7%) mainly due to lower R&D; spend. EBITDA grew 23.8% YoY to | 238 crore against I-direct estimates of | 251 crore Net profit grew 47.4% YoY to | 119.8 crore (I-direct estimate: | 127.6...